12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming

Shares of CrowdStrike have repeatedly hit new all-time highs only to be knocked back—most recently dropping nearly 10% after the Nov. 11 peak—yet remain about 21% above levels at the Q2 report as analysts have grown markedly more bullish (12 price-target raises in November, range $515–$800; consensus $537.49). Management guided Q3 revenue of $1.208–$1.28 billion (≈19% YoY) and EPS of $0.93–$0.95, so the elevated analyst expectations could produce a sharp reversal if results or guidance disappoint, while the company’s post-outage recovery has boosted ARR and investor goodwill. The stock trades at a premium to peers, is vulnerable to sector headline risk, and technically sits near $500—just below the 50-day SMA (~$506.91) with support near $480 and a negative MACD—making the Dec. 2 earnings release a likely catalyst for renewed volatility and directional clarity.

Analysis

CrowdStrike (CRWD) has repeatedly hit new all-time highs only to be knocked back—most recently after the Nov. 11 peak when the stock fell nearly 10%—even as 12 analysts raised price targets in November to a $515–$800 range versus a $537.49 consensus, signaling elevated expectations ahead of the Dec. 2 earnings release. Management had guided Q3 revenue between $1.208 billion and $1.28 billion (≈19% YoY) and EPS of $0.93–$0.95, with the low-end EPS implying flat YoY performance; analysts’ upgrades appear to assume materially stronger results than that guidance. Sector and headline risk remain prominent: CRWD dipped despite a Nasdaq rally after NVDA’s print and was affected by the Nov. 18 CloudFlare outage, while Palo Alto’s strong quarter still saw a >7% stock decline—illustrating fragile sentiment and the risk of multiple cybersecurity names trading off rich valuations. Technically, CRWD trades near $500, just below the 50-day SMA ($506.91) with a negative MACD and light volume; a move toward $480 would align with long-term support, and Dec. 2 earnings should be the primary catalyst for resumed direction and volatility.

Key Decisions for Investors

• Trim or hedge exposure ahead of the Dec. 2 print given elevated analyst targets and premium valuation, as a miss or conservative guidance could trigger a sharp reversal
• Build phased buy orders on weakness toward the $480-$500 support band rather than adding at current levels, using scale-in to manage execution risk
• Monitor revenue, ARR commentary and EPS versus the company guidance closely at the print; if management raises guidance materially, consider adding to conviction
• Use short-term protective hedges (e.g., put options or collars) if maintaining current positions through the earnings event given the combination of light volume, negative MACD and headline-driven sector volatility